Report: Kerrisdale Capital on Up Fintech Holding (TIGR).
The Robinhood of China? If They Liked it at $18, They've got to Love it at $4.00!
New Report: Lion Group Holdings (LGHL) Initiating Coverage. $1.07
Massive Long-Term Potential from Singapore based Rising Fintech Star.
A Fintech that nearly 'has it all' reported impressive...
Report on Citius Pharma (CTXR): North Shore Research Issues a $10 Price Target, a...
We're Up 181% on Citius Pharma (CTXR), Despite its Being Well Below it's Recent High of $4.30. We Now Have Two $10...
Smart For Life to Present at The Noble Capital Markets Eighteenth Annual Investor Conference.
MIAMI, April 14, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leading...
Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...
Two Binary Events Directly Ahead.
As in Months Away, not Years. Share Price up 76% During April.
Adding Fintech, Lion Group Holdings (LGHL) $1.27 to Watch List.
Our Favorite 'Geopolitical' Influenced Idea.
A heads up for bottom fishers on the Lion...
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or...
Surna Cultivation Technologies Signs Contract for New Addition to Product Portfolio
Converted Air Sanitization Product Partnership to Customer Contract in Under Thirty Days
Louisville, Colorado, April 05, 2022 (GLOBE NEWSWIRE) -- CEA Industries...
Adding Smart for Life (SMFL) $0.85 to the Watch List.
Adding another "Broken" IPO to the Watch List.
We're not sure if "broken" is the appropriate description, when...
Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...
New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
